Hartung Hp
About
In The Last Decade
Hartung Hp
17 papers receiving 915 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Pathology and Forensic Medicine 742
- Neurology 263
- Rheumatology 133
- Neurology 109
- Ophthalmology 84
Countries citing papers authored by Hartung Hp
This map shows the geographic impact of Hartung Hp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartung Hp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartung Hp more than expected).
Fields of papers citing papers by Hartung Hp
This network shows the impact of papers produced by Hartung Hp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartung Hp. The network helps show where Hartung Hp may publish in the future.
Co-authorship network of co-authors of Hartung Hp
This figure shows the co-authorship network connecting the top 25 collaborators of Hartung Hp. A scholar is included among the top collaborators of Hartung Hp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartung Hp. Hartung Hp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Review and Analysis of International Case-Control Studies on CCSVI and Multiple Sclerosis | 2 |
| 2 | 100 | |
| 3 | Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) breakdown → | 636 |
| 4 | 68 | |
| 5 | 0 | |
| 6 | 14 | |
| 7 | 38 | |
| 8 | 17 | |
| 9 | The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy. | 1 |
| 10 | Immunological surrogate markers of disease activity in multiple sclerosis. | 3 |
| 11 | [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors]. | 1 |
| 12 | Autoimmunity in the peripheral nervous system. | 14 |
| 13 | [Course of illness and prognosis of multiple sclerosis. 1: The natural illness course]. | 4 |
| 14 | [Multiple sclerosis and pregnancy. Overview and status of the European multicenter PRIMS study]. | 1 |
| 15 | [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies]. | 2 |
| 16 | [Interferon-beta in treatment of relapsing multiple sclerosis]. | 1 |
| 17 | Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. | 30 |
| 18 | Experimental allergic neuritis and Guillain-Barré syndrome: immune mechanisms. A short review. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.